CVE-2017-17512

Public Exploit

Description

sensible-browser in sensible-utils before 0.0.11 does not validate strings before launching the program specified by the BROWSER environment variable, which allows remote attackers to conduct argument-injection attacks via a crafted URL, as demonstrated by a --proxy-pac-file argument.

Category

8.8
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.63%
Vendor Advisory ubuntu.com Vendor Advisory debian.org Vendor Advisory debian.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://usn.ubuntu.com/3584-1/ vendor advisory
https://lists.debian.org/debian-lts-announce/2017/12/msg00012.html mailing list
http://metadata.ftp-master.debian.org/changelogs/main/s/sensible-utils/sensible-utils_0.0.11_changelog release notes vendor advisory
https://bugs.debian.org/881767 third party advisory issue tracking exploit
https://www.debian.org/security/2017/dsa-4071 vendor advisory third party advisory issue tracking

Frequently Asked Questions

What is the severity of CVE-2017-17512?
CVE-2017-17512 has been scored as a high severity vulnerability.
How to fix CVE-2017-17512?
To fix CVE-2017-17512, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-17512 being actively exploited in the wild?
It is possible that CVE-2017-17512 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.